Moreover, the magnitudes of fold changes of the following genes were observed to be higher in the glioma group compared to the control group: CXCL5 (p = 0.018), HLA-C (p = 0.014), and TGFB1 (p = 0.020), see Fig. 1a. The gene discussed is HLA-C; the disease is central nervous system cancer.